Logo

American Heart Association

  35
  0


Final ID:

Accuracy of cardiologist reporting of severe aortic stenosis and its impact on clinical management: Insights from decision-support artificial intelligence applied to 28,491 men and women undergoing echocardiography.

Abstract Body (Do not enter title and authors here): BACKGROUND: Despite established echocardiographic (echo) guidelines, under-reporting of severe AS is common and may delay management. We investigated whether echo measurement-based artificial intelligence (AI) without image recognition can enhance diagnostic accuracy and mitigate diagnostic delays.

METHODS: After excluding prior surgical (SAVR) or transcatheter (TAVI) aortic valve replacement (n=127), left ventricular outflow tract measurement errors (n=183) and a repeat study in the same year (n=2,144), 28,491 adults (mean age 65.02±16.56 years, 52.5% male) undergoing transthoracic echo (July 2022 to June 2023) were included. AI software was retrospectively applied to all echos, with outputs compared to cardiologist-reported AS severity, followed by prospective follow-up of severe cases. To verify AI accuracy, a random sample of cases were selected for blinded image review (two reviewers, with a third to break the tie if any discrepancy).

RESULTS: The AI returned low-probability (n=27,415, 96.1%), medium-probability (n=70, 0.2%), or high-probability (n=1006, 3.5%) of the severe AS phenotype. 784 (77.9%) high-probability cases met severe AS guidelines. Cardiologists reported no, mild, moderate, moderately severe and severe AS in 107 (10.6%), 19 (1.9%), 391 (38.9%), 154 (15.3%) and 335 (33.3%) cases, respectively, confirming under-reporting of severe AS. Randomized blinded image review reinforced this finding: Severe AS was reported as moderate or moderately severe in 67%, moderate AS reported as no or mild AS in 29%. 427 high-probability cases had outpatient cardiology follow-up: 92.5% mentioned AS severity, with conservative management in 51.8% and 80.1% of cardiologist-reported severe and non-severe AS, respectively. Females represented 47.9% of high probability cases, but only 38.4% were reported severe (vs men, 44.2%, p<0.001) despite a similar AVA (0.97±0.33 vs 0.95±0.27 cm2, p=ns) but lower AV gradients (28.0±14.2 vs 32.6±14.4 mmHg respectively, p<0.001). Among AI high-probability echos, a cardiologist report of non-severe AS was associated with a lower mean AV gradient, a higher AVA, lower stroke volume index, and a longer time to referral for SAVR or TAVI evaluation. Symptoms were common in both groups (see table).

CONCLUSIONS: Severe AS misclassification during echo reporting is common, causing management/intervention delays. AI shows significant promise in highlighting the severe AS phenotype, particularly for females and low-gradient AS.
  • Bhat, Vikas  ( University of Notre Dame , Fremantle , Western Australia , Australia )
  • Strange, Geoff  ( NEDA LTD , Perth , Western Australia , Australia )
  • Butcher, Steele  ( Advara Heart Care , Perth , Western Australia , Australia )
  • Deans, Renae  ( Advara Heart Care , Perth , Western Australia , Australia )
  • Mahoney, Thomas  ( Advara Heart Care , Perth , Western Australia , Australia )
  • Barnes, Cara  ( Advara Heart Care , Perth , Western Australia , Australia )
  • Playford, David  ( University of Notre Dame , Fremantle , Western Australia , Australia )
  • Author Disclosures:
    Vikas Bhat: DO NOT have relevant financial relationships | Geoff Strange: DO have relevant financial relationships ; Research Funding (PI or named investigator):Edwards Lifescience:Active (exists now) ; Research Funding (PI or named investigator):AstraZeneca:Active (exists now) ; Research Funding (PI or named investigator):Novartis:Active (exists now) ; Research Funding (PI or named investigator):NEDA:Active (exists now) ; Independent Contractor:Echo IQ:Active (exists now) ; Speaker:Abbott Labratory:Past (completed) ; Speaker:Medtronic:Past (completed) | Steele Butcher: No Answer | Renae Deans: DO NOT have relevant financial relationships | Thomas Mahoney: No Answer | Cara Barnes: No Answer | David Playford: DO have relevant financial relationships ; Advisor:Echo IQ:Active (exists now) ; Research Funding (PI or named investigator):Pfizer:Expected (by end of conference) ; Research Funding (PI or named investigator):BMS:Past (completed) ; Research Funding (PI or named investigator):AstraZeneca:Active (exists now) ; Research Funding (PI or named investigator):Edwards:Active (exists now) ; Research Funding (PI or named investigator):Novartis:Active (exists now) ; Research Funding (PI or named investigator):NEDA:Active (exists now) ; Speaker:Echo IQ:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Trials and Deployments of Artificial Intelligence in Cardiology

Saturday, 11/08/2025 , 03:15PM - 04:30PM

Featured Science

More abstracts on this topic:
A Meta-Analysis Comparing Same-Day Discharge to Later-Day Discharge in Transcatheter Aortic Valve Replacement

Jain Hritvik, Passey Siddhant, Jain Jyoti, Goyal Aman, Wasir Amanpreet, Ahmed Mushood, Patel Nandan, Yadav Ashish, Shah Janhvi, Mehta Aryan

A Bridge from Sweet to Sour: A Case of Recurrent Myocardial Stunning in Diabetic Ketoacidosis

Satish Vikyath, Pargaonkar Sumant, Slipczuk Leandro, Schenone Aldo, Maliha Maisha, Chi Kuan Yu, Sunil Kumar Sriram, Borkowski Pawel, Vyas Rhea, Rodriguez Szaszdi David Jose Javier, Kharawala Amrin, Seo Jiyoung

You have to be authorized to contact abstract author. Please, Login
Not Available